KONE Oyj (OTCMKTS:KNYJY – Get Free Report) posted its earnings results on Thursday. The company reported $0.25 earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.04), Zacks reports. KONE Oyj had a net margin of 8.98% and a return on equity of 39.77%.
KONE Oyj Stock Performance
KNYJY traded down $0.24 during midday trading on Thursday, reaching $25.21. The company had a trading volume of 64,505 shares, compared to its average volume of 37,339. KONE Oyj has a 1 year low of $22.69 and a 1 year high of $30.12. The company has a quick ratio of 0.89, a current ratio of 1.06 and a debt-to-equity ratio of 0.18. The company has a market cap of $22.85 billion, a P/E ratio of 24.48, a P/E/G ratio of 3.32 and a beta of 0.69. The business has a 50-day moving average of $24.88 and a two-hundred day moving average of $26.20.
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada cut shares of KONE Oyj from a “hold” rating to a “strong sell” rating in a research note on Monday, November 25th.
KONE Oyj Company Profile
KONE Oyj, together with its subsidiaries, engages in the elevator and escalator business worldwide. The company provides elevators, escalators, and automatic building doors. It offers maintenance services; and modernization solutions. In addition, the company offers KONE Office Flow, a connected solution that allows for personalized user experiences and touch-free access; health and well-being solutions for elevators, escalators, and doors; KONE Access, an access control system, which is integrated with elevator system and building doors; KONE Destination, a destination control system that reduce waiting and travel times; KONE infotainment, a communication channel for building tenants and visitors; and monitoring solutions that enable real-time inspection of elevators and escalators.
See Also
- Five stocks we like better than KONE Oyj
- Following Congress Stock Trades
- How Value Investors Find Undervalued Stocks and Build Wealth
- The Basics of Support and Resistance
- Is Tonix Pharmaceuticals the Next Biotech Breakout?
- What Are Earnings Reports?
- DeepSeek Dip: Is the Nuclear Energy Sell-Off a Buying Opportunity
Receive News & Ratings for KONE Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KONE Oyj and related companies with MarketBeat.com's FREE daily email newsletter.